Aigerim Sipenova

1 ta ish

Science Management Department, National Research Oncology Center LLP, Astana 010000, Kazakhstan

1. The Role of CD56 as an Immunophenotypic Marker in the Clinical Course of Multiple Myeloma

   Azat Karabekov, Vadim Kemaikin, Zhandos Burkitbayev +15

   MaqolaMultiple Myeloma Research and TreatmentsJournal of Clinical Medicine20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.article.015051